相关实验视频
Updated: May 11, 2026

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.4K
用左心室辅助装置适应生活的措施的响应有效性:来自MCS A-QOL研究的发现
Elizabeth A Hahn1, Larry A Allen2, David Cella1
1Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL.
JHLT open
|June 9, 2025
概括
五个心室辅助器件 (VAD) 特定的患者报告结果 (PRO) 测量结果显示,患者在VAD植入后3至6个月内对变化的敏感性. 这些PRO可以帮助临床医生指导VAD患者,改善生活质量.
科学领域:
- 心脏病学 心脏病学
- 医疗器械研究 医疗器械研究
- 患者报告的结果
背景情况:
- 室腔辅助器件 (VAD) 对于末期心力衰竭管理至关重要.
- 评估患者在VAD植入后的调整和生活质量至关重要.
- 需要验证的患者报告结果 (PROs) 来跟踪VAD患者的进展.
研究的目的:
- 评估五个特定于VAD的PRO措施的响应有效性 (对变化的敏感性).
- 为了确定这些PRO是否可以检测患者状态在VAD后3至6个月的变化.
主要方法:
- 在12个美国地点进行前性研究.
- 患者在VAD后3个月和6个月完成了VAD特定的PRO和通用健康措施.
- 统计分析包括线性混合效应模型和ANOVA来评估随时间变化.
主要成果:
- 五个特定于VAD的PRO措施显示了初步的响应变化的证据.
- 从第3个月到第6个月,PRO分数的变化与患者报告的变化相关 (更好,没有变化,更差).
- 特定于VAD的PRO对患者的临床变化表现出敏感性.
结论:
- 特定于VAD的PRO措施对患者在植入后3至6个月的病情变化敏感.
- 这些PRO可以帮助临床医生向患者提供关于VAD的信息,并确定干预的领域.
- 使用这些措施可以支持患者的调整,并提高VAD植入后的生活质量.
相关概念视频
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

